NCT00375973View on ClinicalTrials.gov

Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

June 30, 2012

Study Completion Date

March 31, 2014

Conditions
Fatigue Syndrome, Chronic
Interventions
DRUG

Duloxetine

Duloxetine po 60-120 mg/day for 12 weeks

DRUG

Placebo

Sugar pill dose comparable to duloxetine

Trial Locations (1)

45219

Women's Health Research Program, Cincinnati

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

University of Cincinnati

OTHER

NCT00375973 - Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome | Biotech Hunter | Biotech Hunter